Article PDF
Avoid common mistakes on your manuscript.
References
Garnett CE, Beasley N, Bhattaram VA, et al. Concentration-QT relationships play a key role in the evaluation of proarrhythmic risk during regulatory review. J Clin Pharmacol. 2008;48:13–18.
Darpo B, Benson C, Dota C, et al. Results from the IQ-CSRC prospective study support replacement of the thorough QT study by QT assessment in the early clinical phase. Clin Pharmacol Ther. 2015; 97:326–335.
Darpo B, Garnett C. Early QT assessment—how can our confidence in the data be improved? Br J Clin Pharmacol. 2013;76:642–648.
Westerberg G, Chiesa JA, Andersen CA, et al. Safety, pharmacokinetics, pharmacogenomics and QT concentration-effect modelling of the SirT1 inhibitor selisistat in healthy volunteers. Br J Clin Pharmacol. 2015;79:477–491.
Zhang J, Chen H, Tsong Y, Stockbridge N. Lessons learned from hundreds of thorough QT studies. Therapeutic Innovation & Regulatory Science. 2015;49:392–397.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Darpo, B., Ferber, G., Garnett, C. et al. Topic of Timely Interest—Decision Criteria for Negative QT Assessment Using Exposure Response Analysis of Data From Early-Phase Clinical Studies: Letter to the Editor. Ther Innov Regul Sci 49, 717–719 (2015). https://doi.org/10.1177/2168479015596022
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1177/2168479015596022